MFAP2 and endometrial cancer: In summary, our study integrates a complex proteomic landscape into actionable insights for endometrial cancer using the SHAP method for model interpretation—a novel approach that reveals the complex impact of individual proteins such as EWSR1 and MFAP2 on disease subtyping.